Nasal Shedding of Equine Herpesvirus-1 from Horses in an Outbreak of Equine Herpes Myeloencephalopathy in Western Canada

Journal of Veterinary Internal Medicine

Volumn 26, Issue 2, 2012, Pages 384-392

  Burgess, B A ^a,b,c   Tokateloff, N ^a,b   Manning, S ^a,b   Lohmann, K ^a,b   Lunn, D P ^c   Hussey, S B ^c   Morley, P S ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

EHV 1; Myeloencephalitis; Neurologic; PCR

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CANADA; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EQUINE HERPES VIRUS; FEMALE; GENETICS; HERPES VIRUS INFECTION; HORSE; HORSE DISEASE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MALE; NEUROLOGIC DISEASE; NOSE MUCOSA; POLYMERASE CHAIN REACTION; STATISTICAL MODEL; VIROLOGY; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; DISEASE OUTBREAKS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HORSE DISEASES; HORSES; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; NASAL MUCOSA; NERVOUS SYSTEM DISEASES; POLYMERASE CHAIN REACTION; SASKATCHEWAN; VIRUS SHEDDING;

ANIMALIA; EQUID HERPESVIRUS 1; EQUIDAE; EQUINE HERPESVIRUS SP.; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

EID: 84858750132     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.00885.x     Document Type: Article

References (23)

1. Kohn CW, Fenner WR. Equine herpes myeloencephalopathy. Vet Clin North Am Equine Pract 1987;3:405-419.
2. Borchers K, Thein R, Sterner-Kock A. Pathogenesis of equine herpesvirus-associated neurological disease: A revised explanation. Equine Vet J 2006;38:283-287.
3. Allen GP. Development of a real-time polymerase chain reaction assay for rapid diagnosis of neuropathogenic strains of equine herpesvirus-1. J Vet Diagn Invest 2007;19:69-72.
4. Allen GP, Bolin DC, Bryant U, et al. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Equine Vet J 2008;40:105-110.
5. Kydd JH, Smith KC. Equine herpesvirus neurologic disease: Reflections from across the pond. J Vet Intern Med 2006;20:467-468.
6. Nugent J, Birch-Machin I, Smith KC, et al. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J Virol 2006;80:4047-4060.
7. Perkins GA, Goodman LB, Tsujimura K, et al. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007). Vet Microbiol 2009;139:375-378.
8. Kohn CW, Reed SM, Sofaly CD, et al. Transmission of EHV-1 by horses with EHV-1 myeloencephalopathy: Implications for biosecurity and review. Clin Tech Equine Pract 2006;5:60-66.
9. Hussey SB, Clark R, Lunn KF, et al. Detection and quantification of equine herpesvirus-1 viremia and nasal shedding by real-time polymerase chain reaction. J Vet Diagn Invest 2006;18:335-342.
10. Allen GP, Breathnach CC. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic versus non-neuropathogenic strains of EHV-1. Equine Vet J 2006;38:252-257.
11. Perkins GA, Goodman LB, Dubovi EJ, et al. Detection of equine herpesvirus-1 in nasal swabs of horses by quantitative real-time PCR. J Vet Intern Med 2008;22:1234-1238.
12. Edington N, Bridges CG, Patel JR. Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: Equine stroke. Arch Virol 1986;90:111-24.
13. USDA. Equine Herpes Myeloencephalopathy: Mitigation, Experiences, Lessons Learned, and Future Needs. USDA-APHIS-VS, CEAH. Fort Collins, CO; 2008:#N522.0708.
14. Anonymous. American Association of Equine Practitioners Guidelines on Infectious Disease Outbreak Control, 2006: [accessed June 17, 2009].
15. Lunn DP, Davis-Poynter N, Flaminio MJBF, et al. Equine herpesvirus-1 consensus statement. J Vet Intern Med 2009;23:450-461.
16. Henninger RW, Reed SM, Saville WJ, et al. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. J Vet Intern Med 2007;21:157-65.
17. Morley PS, Townsend HGG, Bogdan JR, et al. Descriptive epidemiologic study of disease associated with influenza virus infections during three epidemics in horses. J Am Vet Med Assoc 2000;216:535-544.
18. Cowell RL, Tyler RL. Diagnostic Cytology and Hematology of the Horse, 2nd ed. St. Louis, MO: Mosby, Inc; 2002: 174.
19. Goehring LS, Landolt GA, Morley PS. Detection and management of an outbreak of equine herpesvirus type 1 infection and associated neurological disease in a veterinary teaching hospital. J Vet Intern Med 2010;24:1176-1183.
20. Goehring LS, van Winden SC, van Maanen C, et al. Equine herpesvirus type 1-associated myeloencephalopathy in The Netherlands: A four-year retrospective study (1999-2003). J Vet Intern Med 2006;20:601-607.
21. Friday PA, Scarratt WK, Elvinger F, et al. Ataxia and paresis with equine herpesvirus type 1 infection in a herd of riding school horses. J Vet Intern Med 2000;14:197-201.
22. van Maanen C, Sloet van Oldruitenborgh-Oosterbaan MM, Damen EA, et al. Neurological disease associated with EHV-1 infection in a riding school: Clinical and virological characteristics. Equine Vet J 2001;33:191-196.
23. Allen GP. Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am J Vet Res 2008;69:1595-1600.